NASDAQ:MYGN Investor Notice: Lawsuit Alleges Misleading Statements by Myriad Genetics, Inc.

San Diego, CA -- (SBWIRE) -- 10/18/2019 -- An investor, who purchased shares of Myriad Genetics, Inc. (NASDAQ: MYGN), filed a lawsuit over alleged violations of Federal Securities Laws by Myriad Genetics, Inc.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.